Logo image of SYENS.BR

SYENSQO SA (SYENS.BR) Stock Fundamental Analysis

EBR:SYENS - Euronext Brussels - BE0974464977 - Common Stock - Currency: EUR

64.55  -1.17 (-1.78%)

Fundamental Rating

4

SYENS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 66 industry peers in the Chemicals industry. Both the profitability and the financial health of SYENS get a neutral evaluation. Nothing too spectacular is happening here. SYENS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SYENS had positive earnings in the past year.
In the past year SYENS had a positive cash flow from operations.
In multiple years SYENS reported negative net income over the last 5 years.
In the past 5 years SYENS always reported a positive cash flow from operatings.
SYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFSYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

SYENS has a Return On Assets (-0.04%) which is in line with its industry peers.
SYENS has a Return On Equity (-0.07%) which is in line with its industry peers.
SYENS has a Return On Invested Capital (3.24%) which is in line with its industry peers.
SYENS had an Average Return On Invested Capital over the past 3 years of 8.47%. This is above the industry average of 6.30%.
The 3 year average ROIC (8.47%) for SYENS is well above the current ROIC(3.24%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.04%
ROE -0.07%
ROIC 3.24%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
SYENS.BR Yearly ROA, ROE, ROICSYENS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

SYENS's Operating Margin of 6.59% is fine compared to the rest of the industry. SYENS outperforms 60.61% of its industry peers.
SYENS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 32.42%, SYENS is in line with its industry, outperforming 51.52% of the companies in the same industry.
SYENS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.59%
PM (TTM) N/A
GM 32.42%
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
SYENS.BR Yearly Profit, Operating, Gross MarginsSYENS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

More info and screens

5

2. Health

2.1 Basic Checks

SYENS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SYENS has less shares outstanding than it did 1 year ago.
SYENS has a better debt/assets ratio than last year.
SYENS.BR Yearly Shares OutstandingSYENS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SYENS.BR Yearly Total Debt VS Total AssetsSYENS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 2.19 indicates that SYENS is not a great score, but indicates only limited risk for bankruptcy at the moment.
SYENS has a Altman-Z score (2.19) which is in line with its industry peers.
SYENS has a debt to FCF ratio of 9.75. This is a negative value and a sign of low solvency as SYENS would need 9.75 years to pay back of all of its debts.
SYENS's Debt to FCF ratio of 9.75 is fine compared to the rest of the industry. SYENS outperforms 62.12% of its industry peers.
SYENS has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.25, SYENS is in the better half of the industry, outperforming 68.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 9.75
Altman-Z 2.19
ROIC/WACC0.47
WACC6.88%
SYENS.BR Yearly LT Debt VS Equity VS FCFSYENS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

SYENS has a Current Ratio of 1.71. This is a normal value and indicates that SYENS is financially healthy and should not expect problems in meeting its short term obligations.
SYENS has a Current ratio (1.71) which is in line with its industry peers.
A Quick Ratio of 1.05 indicates that SYENS should not have too much problems paying its short term obligations.
The Quick ratio of SYENS (1.05) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.05
SYENS.BR Yearly Current Assets VS Current LiabilitesSYENS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SYENS have decreased strongly by -102.63% in the last year.
Looking at the last year, SYENS shows a decrease in Revenue. The Revenue has decreased by -3.10% in the last year.
The Revenue has been growing slightly by 4.31% on average over the past years.
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.54%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-51.19%

3.2 Future

SYENS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.44% yearly.
Based on estimates for the next years, SYENS will show a small growth in Revenue. The Revenue will grow by 4.24% on average per year.
EPS Next Y6.78%
EPS Next 2Y12%
EPS Next 3Y12.22%
EPS Next 5Y10.44%
Revenue Next Year1.22%
Revenue Next 2Y2.83%
Revenue Next 3Y3.48%
Revenue Next 5Y4.24%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SYENS.BR Yearly Revenue VS EstimatesSYENS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
SYENS.BR Yearly EPS VS EstimatesSYENS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

SYENS is valuated correctly with a Price/Earnings ratio of 12.25.
89.39% of the companies in the same industry are more expensive than SYENS, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.91, SYENS is valued rather cheaply.
The Price/Forward Earnings ratio is 11.47, which indicates a very decent valuation of SYENS.
78.79% of the companies in the same industry are more expensive than SYENS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.85, SYENS is valued a bit cheaper.
Industry RankSector Rank
PE 12.25
Fwd PE 11.47
SYENS.BR Price Earnings VS Forward Price EarningsSYENS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SYENS indicates a somewhat cheap valuation: SYENS is cheaper than 77.27% of the companies listed in the same industry.
SYENS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 31.05
EV/EBITDA 6.92
SYENS.BR Per share dataSYENS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as SYENS's earnings are expected to grow with 12.22% in the coming years.
PEG (NY)1.81
PEG (5Y)N/A
EPS Next 2Y12%
EPS Next 3Y12.22%

More info and screens

1

5. Dividend

5.1 Amount

SYENS has a Yearly Dividend Yield of 1.74%.
Compared to an average industry Dividend Yield of 3.12, SYENS has a dividend in line with its industry peers.
SYENS's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.74%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SYENS.BR Yearly Dividends per shareSYENS.BR Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of SYENS are negative and hence is the payout ratio. SYENS will probably not be able to sustain this dividend level.
DP-3400%
EPS Next 2Y12%
EPS Next 3Y12.22%
SYENS.BR Yearly Income VS Free CF VS DividendSYENS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 500M -500M -1B

More info and screens

SYENSQO SA

EBR:SYENS (5/23/2025, 5:29:56 PM)

64.55

-1.17 (-1.78%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-15 2025-05-15
Earnings (Next)07-31 2025-07-31
Inst Owners27.72%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.74B
Analysts79.29
Price Target86.11 (33.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.74%
Yearly Dividend1.63
Dividend Growth(5Y)N/A
DP-3400%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.09%
Min EPS beat(2)-38.67%
Max EPS beat(2)-7.51%
EPS beat(4)1
Avg EPS beat(4)-8.68%
Min EPS beat(4)-38.67%
Max EPS beat(4)23.87%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.96%
Min Revenue beat(2)-4.61%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-3.51%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)-1.3%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.64%
PT rev (3m)-10.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-71.99%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.66%
Revenue NY rev (1m)-2.58%
Revenue NY rev (3m)-2.72%
Valuation
Industry RankSector Rank
PE 12.25
Fwd PE 11.47
P/S 0.98
P/FCF 31.05
P/OCF 8.01
P/B 0.91
P/tB 2.15
EV/EBITDA 6.92
EPS(TTM)5.27
EY8.16%
EPS(NY)5.63
Fwd EY8.72%
FCF(TTM)2.08
FCFY3.22%
OCF(TTM)8.06
OCFY12.48%
SpS65.58
BVpS71.21
TBVpS30.03
PEG (NY)1.81
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.04%
ROE -0.07%
ROCE 4.32%
ROIC 3.24%
ROICexc 3.48%
ROICexgc 6.24%
OM 6.59%
PM (TTM) N/A
GM 32.42%
FCFM 3.17%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
ROICexc(3y)9.08%
ROICexc(5y)8.08%
ROICexgc(3y)19%
ROICexgc(5y)18.92%
ROCE(3y)11.29%
ROCE(5y)10.17%
ROICexcg growth 3Y-19.3%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.3%
ROICexc growth 5YN/A
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 9.75
Debt/EBITDA 1.54
Cap/Depr 85.25%
Cap/Sales 9.12%
Interest Coverage 250
Cash Conversion 71.09%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.05
Altman-Z 2.19
F-Score5
WACC6.88%
ROIC/WACC0.47
Cap/Depr(3y)98.43%
Cap/Depr(5y)76.05%
Cap/Sales(3y)9.47%
Cap/Sales(5y)8.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.54%
EPS Next Y6.78%
EPS Next 2Y12%
EPS Next 3Y12.22%
EPS Next 5Y10.44%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-51.19%
Revenue Next Year1.22%
Revenue Next 2Y2.83%
Revenue Next 3Y3.48%
Revenue Next 5Y4.24%
EBIT growth 1Y-33.42%
EBIT growth 3Y-0.36%
EBIT growth 5YN/A
EBIT Next Year59.96%
EBIT Next 3Y23.63%
EBIT Next 5Y15.21%
FCF growth 1Y-48.94%
FCF growth 3Y-7.48%
FCF growth 5YN/A
OCF growth 1Y-34.04%
OCF growth 3Y7.55%
OCF growth 5YN/A